Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.

Biocon Limited

Biocon is a biopharmaceutical company that provides access to affordable quality medicines. It is involved in developing and manufacturing a range of pharmaceuticals, including generics, biosimilars, and novel biologics.

COM:BIOCON

Biocon

Last Close

331.50

25/11 09:40

Market Cap

425.67B

Beta: -

Volume Today

1.24M

Avg: -

Financials Not Available